Cargando…
Metformin impairs cisplatin resistance effects in A549 lung cancer cells through mTOR signaling and other metabolic pathways
Lung cancer is the leading cause of cancer-associated death worldwide and exhibits intrinsic and acquired therapeutic resistance to cisplatin (CIS). The present study investigated the role of mTOR signaling and other signaling pathways after metformin (MET) treatment in control and cisplatin-resista...
Autores principales: | Morelli, Ana Paula, Tortelli, Tharcísio Citrângulo, Pavan, Isadora Carolina Betim, Silva, Fernando Riback, Granato, Daniela Campos, Peruca, Guilherme Francisco, Pauletti, Bianca Alves, Domingues, Romênia Ramos, Bezerra, Rosangela Maria Neves, De Moura, Leandro Pereira, Leme, Adriana Franco Paes, Chammas, Roger, Simabuco, Fernando Moreira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041480/ https://www.ncbi.nlm.nih.gov/pubmed/33846781 http://dx.doi.org/10.3892/ijo.2021.5208 |
Ejemplares similares
-
STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma
por: Morelli, Ana Paula, et al.
Publicado: (2021) -
deltaXpress (ΔXpress): a tool for mapping differentially correlated genes using single-cell qPCR data
por: Murillo Carrasco, Alexis Germán, et al.
Publicado: (2023) -
Checking NEKs: Overcoming a Bottleneck in Human Diseases
por: Peres de Oliveira, Andressa, et al.
Publicado: (2020) -
ADAM17 mediates OSCC development in an orthotopic murine model
por: Simabuco, Fernando Moreira, et al.
Publicado: (2014) -
The Hallmarks of Flavonoids in Cancer
por: Ponte, Luis Gustavo Saboia, et al.
Publicado: (2021)